Related Experiment Videos
Hypocalcemia and chromosome 22q11 microdeletion
1Unité CNRS UPR 1524, Hôpital Saint Vincent de Paul, Paris, France.
Genetic Counseling (Geneva, Switzerland)
|January 13, 2000
Summary
Hypocalcemia is common in 22q11 microdeletion syndrome, presenting varied symptoms from mild to severe. Early diagnosis and monitoring of serum calcium are crucial for affected individuals.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Hypocalcemia, a condition of low serum calcium, has diverse etiologies.
- 22q11 microdeletion is associated with a high incidence of hypocalcemia.
- The presentation of hypocalcemia in 22q11 microdeletion ranges from asymptomatic to severe hypoparathyroidism.
Purpose of the Study:
- To review the diagnosis, causes, prevention, and treatment of hypocalcemia.
- To highlight the strong association between hypocalcemia and 22q11 microdeletion.
- To emphasize the varied clinical spectrum of hypocalcemia in this genetic syndrome.
Main Methods:
- Literature review on hypocalcemia and 22q11 microdeletion.
- Analysis of clinical presentations and diagnostic approaches.
- Synthesis of current knowledge on prevention and treatment strategies.
Main Results:
- 22q11 microdeletion is a significant risk factor for hypocalcemia.
- Hypocalcemia in 22q11 microdeletion can manifest at any age, including late-onset forms.
- Associated hypoparathyroidism is a common feature, but not always present.
Conclusions:
- Genetic analysis of the 22q11 region is recommended for patients with unexplained late-onset or recurrent hypoparathyroidism.
- Systematic serum calcium monitoring is advised for individuals with known 22q11 microdeletion, particularly during critical life stages and health events.
- Early detection and management of hypocalcemia are vital for improving outcomes in patients with 22q11 microdeletion.